Soluble cyanine dye/β-cyclodextrin derivatives: Potential carriers for drug delivery and optical imaging
Source abstract
Abstract
Abstract Two soluble cyanine/β-cyclodextrin derivatives have been synthesized under simultaneous ultrasound/microwave irradiation. UV–Vis, steady-state, time-resolved fluorescence and circular dichroism spectroscopies were used to evaluate their photophysical properties, as well as to study their complexation with the anticancer drug doxorubicin. Titration experiments were performed by monitoring corrected emission intensity. The analysis of fluorescence data provided stability constants for doxorubicin complexes with cyanine/β-cyclodextrins which are 4 orders of magnitude greater than those reported for its complexation with native β-cyclodextrin and one order greater than its association with DNA. The complexation has also been studied using Molecular Mechanics and Molecular Dynamics simulations. Both electrostatic and van de Waals binding energy contributions are important to system stabilization. The potential use of these systems as carriers has been evaluated via in vitro experiments on HeLa cells and by monitoring cell entrance via confocal laser scanning microscopy.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Lanthanide and Transition Metal Complexes · Electron Spin Resonance Studies
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (69)
Show source-provided references
1. Syntheses of cyanines: a review10.1016/j.tet.2011.10.069 ↗
2. Strekowski · 2008
3. Synthesis and applications of unsymmetrical carbocyanine dyes10.1016/j.dyepig.2013.08.001 ↗
4. Target-specific nanoparticles containing a broad band emissive NIR dye for the sensitive detection and characterization of tumor development10.1016/j.biomaterials.2012.09.028 ↗
5. Application of photonic crystal enhanced fluorescence to cancer biomarker microarrays10.1021/ac102989n ↗
6. Fluorescent labeling of biomolecules with organic probes10.1021/cr0783840 ↗
7. Szejtli · 1982
8. Chemical sensors based on cyclodextrin derivatives10.3390/s8084961 ↗
9. Photostable cyanine dye β-cyclodextrin conjugates10.1016/S0040-4039(97)01426-3 ↗
10. Synthesis, spectral properties of cyanine dyes-β-cyclodextrin and their application as the supramolecular host with spectroscopic probe10.1016/j.dyepig.2012.08.010 ↗
11. Topics in inclusion science
12. A sonochemical protocol to the synthesis of permodified cyclodextrins10.1081/CAR-100106932 ↗
13. Recent advances in the synthesis of cyclodextrin derivatives under microwaves and power ultrasound10.1007/s10847-006-9169-z ↗
14. Synthesis of water-soluble multidentate aminoalcohol β-cyclodextrin derivatives via epoxide opening10.1016/j.carres.2011.09.018 ↗
15. A new class of cationic cyclodextrins: synthesis and chemico-physical properties10.1039/c0nj00021c ↗
16. Alkyne-azide click reaction catalyzed by metallic copper under ultrasound10.1038/nprot.2010.1 ↗
17. DNA topoisomerase II structures and anthracycline activity: insights into ternary complex formation10.2174/138161207781757105 ↗
18. Anthracyclines: molecular advances and pharmacologic developments in antitumor activity and cardiotoxicity10.1124/pr.56.2.6 ↗
19. Structure-dependent complexation of Fe3+ by anthracyclines. 1. The importance of pendant hydroxyl functionality10.1021/jp402349e ↗
20. A close-up on doxorubicin binding to γ-cyclodextrin: an elucidating spectroscopic, photophysical and conformational study10.1039/c2ra01221a ↗
21. The benefits and challenges associated with the use of drug delivery systems in cancer therapy10.1016/j.bcp.2010.04.020 ↗
22. Polymeric micelles as a new drug carrier system and their required considerations for clinical trials10.1517/17425240903436479 ↗
23. Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulation10.1016/j.addr.2009.11.028 ↗
24. Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation10.2217/17435889.2.2.219 ↗
25. Yallapu · Pharm Res Chem Intermed · 2010 · 27 · 2283
26. Porous metal-organic-framework nanoscale carriers as a potential platform for drug delivery and imaging10.1038/nmat2608 ↗
27. Nanoparticle therapeutics: an emerging treatment modality for cancer10.1038/nrd2614 ↗
28. Development of the polymer micelle carrier system for doxorubicin10.1016/S0168-3659(01)00341-8 ↗
29. Complexation of doxorubicin with β- and γ-cyclodextrins10.1366/0003702924124943 ↗
30. Cyclodextrin drug carrier systems10.1021/cr970025p ↗
31. Effect of cyclodextrin complexation on the chemical stability of doxorubicin and daunorubicin in aqueous solutions10.1016/0378-5173(91)90050-X ↗
32. Inclusion complexation of doxorubicin and daunorubicin with cyclodextrins10.1016/0731-7085(90)80100-4 ↗
33. Inclusion complex formation of anthracycline antibiotics with cyclodextrins; a proton nuclear magnetic resonance and molecular modeling study10.1007/BF01153301 ↗
34. DNABinding parameters of daunorubicin and doxorubicin in the conditions used for studying the interaction of anthracycline−DNA complexes with cells in vitro10.1007/BF00253097 ↗
35. Inclusion of chemotherapeutic agents in substituted β-cyclodextrin derivatives10.1007/s10847-010-9741-4 ↗
36. Preparation of a cyclodextrin conjugated with two arbutin moieties as a drug-carrier model, and its high ability for the inclusion of doxorubicin10.2174/157018006776286925 ↗
37. Intermolecular interactions between doxorubicin and β-cyclodextrin 4-methoxyphenol conjugates10.1021/jp2091363 ↗
38. Cyclodextrin derivatives conjugated with aromatic moieties as pH responsive drug carriers for anthracycline10.1021/jp4060632 ↗
39. Ultrasound-promoted copper-catalyzed azide-alkyne cycloaddition10.1021/cc900150d ↗
40. Standards for photoluminescence quantum yield measurements in solution10.1351/PAC-REP-10-09-31 ↗
41. Deconvolution of fluorescence decay curves. A critical comparison of techniques10.1021/j100473a019 ↗
42. Lakowicz · 2006 · 97
43. Fluorescence anisotropy
44. Lakowicz · 2006 · 56
45. Instrumentation for fluorsecence spectroscopy
46. Binding of a neutral guest to cucurbiturils: photophysics, thermodynamics and molecular modelling10.1080/10610278.2013.844818 ↗
47. Fluorescence methods for studies of cyclodextrins inclusion complexation and excitation transfer in cyclodextrin complexes
48. St Louis, MO, 63144 USA: SybylX 2.0, Tripos International, 1699 S Hanley Road; 2013.
49. Validation of the general purpose Tripos 5.2 force field10.1002/jcc.540100804 ↗
50. Frisch · 2009
51. Program of minimization of the empirical energy of a molecule by a simple method10.1016/0040-4020(75)80129-3 ↗
52. Molecular silverware. I. General solutions to excluded volume constrained problems10.1002/jcc.540120214 ↗
53. Rationalizing some experimental facts on the complexation of 2-methyl naphthalenecarboxylate and hydroxypropyled cyclodextrins by molecular mechanics and molecular dynamics10.1007/s10847-006-9157-3 ↗
54. Fluorescence, induced circular dichroism and molecular mechanics of 1-methyl naphthalenecarboxylate complexes with 2-hydroxypropyl cyclodextrins10.1007/s10895-008-0432-0 ↗
55. Complexation of dimethyl 2,3-naphthalenedicarboxylate with 2-hydroxypropyl-α-, -β- and -γ-cyclodextrins in aqueous solution by fluorescence, circular dichroism and molecular mechanics10.1007/s10895-008-0360-z ↗
56. Thermodynamics of complexation of dimethyl esters of tere-, iso-, and phthalic acids with α- and β-cyclodextrins10.1366/0003702041389283 ↗
57. Binding of dimethyl 2,3-naphthalenedicarboxylate with α-, β- and γ-cyclodextrins in aqueous solution10.1016/j.saa.2006.07.039 ↗
58. Study of the conformational and self-aggregation properties of 2I,3I-O-(o-xylylene)-per-O-Me-α- and -β-cyclodextrins by fluorescence and molecular Modeling10.1021/jp077670c ↗
59. Thermodynamics of the Dimer formation of 2I,3I-O-(o-xylylene)-per-O-Me-γ-cyclodextrin: fluorescence, molecular mechanics and molecular dynamics10.1007/s10895-009-0497-4 ↗
60. Characterization of covalent Adriamycin-DNA adducts10.1073/pnas.95.20.11561 ↗
61. Unravelling molecular mechanisms in the fluorescence spectra of doxorubicin in aqueous solution by femtosecond fluorescence spectroscopy10.1039/c2cp44056c ↗
62. Induced circular dichroism spectrum of a α-cyclodextrin complex with heptylviologen10.1246/bcsj.62.1154 ↗
63. Complex formation between heptylviologen and cyclodextrin10.1246/bcsj.59.2032 ↗
64. Sign of circular dichroism induced by Î2-cyclodextrin10.1021/j100159a005 ↗
65. A general rule for circular dichroism induced by a chiral macrocycle10.1021/ja00062a040 ↗
66. Exciton chirality methods: principles and application
67. Cyclodextrins10.1177/0192623307310945 ↗
68. Mechanisms of drug release from cyclodextrin complexes10.1016/S0169-409X(98)00052-0 ↗
69. Amiji · 2006